NCT02435199View on ClinicalTrials.gov

Clinical Trial Designed to Determine the Safety and Efficacy of EMA401 in Patients With Painful Diabetic Neuropathy

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

June 30, 2015

Primary Completion Date

October 31, 2016

Study Completion Date

December 31, 2016

Conditions
Diabetic Neuropathies
Interventions
DRUG

EMA401 600mg

DRUG

Placebo

Sponsors

Collaborators (1)

Syneos Health
All Listed Sponsors
collaborator

Syneos Health

OTHER

lead

Spinifex Pharmaceuticals Pty Ltd

INDUSTRY